Company news

July 14, 2014

Indianapolis-based EmotEd LLC, recently spun out of the Indiana University School of Medicine, received nearly $200,000 from the National Institutes of Health to develop video games to diagnose and improve emotional health. The company is based on research by EmotEd founder Dawn Newmann, a research professor at the medical school who also works at Rehabilitation Hospital of Indiana. The NIH money, which came via a Phase I Small Business Technology Transfer award, will allow EmotEd to build an initial platform and test it in a clinical setting. EmotEd will continue to seek non-dilutive funding through Phase II STTR mechanisms and through the Department of Defense.

Indianapolis-based Activate Healthcare is expanding its employer health care clinic operations into Wisconsin, according to Modern Healthcare magazine. Activate already manages 20 near- or on-site health clinics, used by 40 employers, in Indiana, Michigan, Ohio and Washington. Activate was created in 2009 by former Steak n Shake CEO Peter Dunn and ex-Harvard Vanguard Medical Associates CEO Debra Geihsler. Its clients include Monroe County government in Bloomington as well as Monarch Beverage Co. and Major Tool Co. in Indianapolis. Activate is one of a handful of Indiana-based clinic operators that have been growing rapidly and expanding into other states.

Indianapolis-based WellPoint Inc. this month started offering 4 million patients the ability to have e-visits with doctors, while Aetna Inc. says it will boost online access to 8 million people next year from 3 million now, according to Bloomberg News. The health insurers are joining companies such as Teladoc Inc., MDLive Inc. and American Well Corp. that offer virtual visits with doctors who, in some states, can prescribe drugs for anything from sinus infections to back pain. In Indiana, legislation passed this year gave the green light to WellPoint and American Well to partner with the American Health Network physician group to conduct a pilot program of the technology.

Biomet Inc. reported preliminary profit for the past 12 months of $36.8 million on sales of $3.22 billion. That's an improvement in profit of $660 million from fiscal 2013’s $623 million loss on consolidated net sales of $3.05 billion, according to the Fort Wayne Journal Gazette. Excluding extraordinary items, the Warsaw-based company earned $420 million for the year ended May 31. Biomet also reported fiscal fourth-quarter profit of $66.7 million on sales of $845 million, a $288 million improvement over the same period a year earlier when the company posted a $221 million loss on sales of $784 million. Zimmer Inc. in April offered to acquire Biomet for $13.35 billion. The Federal Trade Commission is considering implications of allowing the competitors to merge.